These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2829717)

  • 21. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones.
    Malik M; Mustaev A; Schwanz HA; Luan G; Shah N; Oppegard LM; de Souza EC; Hiasa H; Zhao X; Kerns RJ; Drlica K
    Nucleic Acids Res; 2016 Apr; 44(7):3304-16. PubMed ID: 26984528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
    Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allicin, a natural antimicrobial defence substance from garlic, inhibits DNA gyrase activity in bacteria.
    Reiter J; Hübbers AM; Albrecht F; Leichert LIO; Slusarenko AJ
    Int J Med Microbiol; 2020 Jan; 310(1):151359. PubMed ID: 31585716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of action of the quinolone antimicrobial agents.
    Hooper DC; Wolfson JS
    Rev Infect Dis; 1988; 10 Suppl 1():S14-21. PubMed ID: 2831608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis.
    Onodera Y; Okuda J; Tanaka M; Sato K
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1800-4. PubMed ID: 12019093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo sequential selection of Escherichia coli with topoisomerase- and efflux-mediated misleading quinolone resistance phenotypes.
    Smati M; Emond JP; Arlet G; Tankovic J
    Microb Drug Resist; 2012 Feb; 18(1):19-22. PubMed ID: 22043806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.
    Hoshino K; Sato K; Akahane K; Yoshida A; Hayakawa I; Sato M; Une T; Osada Y
    Antimicrob Agents Chemother; 1991 Feb; 35(2):309-12. PubMed ID: 1850968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.
    Zweerink MM; Edison A
    Antimicrob Agents Chemother; 1986 Apr; 29(4):598-601. PubMed ID: 3010848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
    J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative.
    Wentland MP; Perni RB; Dorff PH; Rake JB
    J Med Chem; 1988 Sep; 31(9):1694-7. PubMed ID: 2842501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
    Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
    Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Masecar BL; Robillard NJ
    Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.
    Cullen ME; Wyke AW; Kuroda R; Fisher LM
    Antimicrob Agents Chemother; 1989 Jun; 33(6):886-94. PubMed ID: 2548439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.
    Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H
    Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae.
    Roychoudhury S; Twinem TL; Makin KM; McIntosh EJ; Ledoussal B; Catrenich CE
    J Antimicrob Chemother; 2001 Jul; 48(1):29-36. PubMed ID: 11418510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.